https://businessofcannabis.com/research/multinational-association-of-supportive-care-in-cancer-mascc-expert-opinion-consensus-guidance-on-the-use-of-cannabinoids-for-gastrointestinal-symptoms-in-patients-with-cancer/
Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on...
Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in...
supportive carein cancerexpert opinionmultinationalassociation
https://repository.up.ac.za/items/c88bad9b-2459-4b38-8f4d-d35e4b99bdb3
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice...
The immune checkpoints associated with the CTLA-4 and PD-1 pathways are critical modulators of immune activation. These pathways dampen the immune response by...
supportive carein cancerclinical practicemultinationalassociation
https://pubmed.ncbi.nlm.nih.gov/27664248/?dopt=Abstract
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced...
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced...
for themasccesmoguidelineupdate
https://oncodaily.com/dialogues/357789
How Will Supportive Care for Cancer Survivors Evolve by 2030? | MASCC 2025 - OncoDaily
Sep 18, 2025 - How Will Supportive Care for Cancer Survivors Evolve by 2030? | MASCC 2025 / cancer, cancer care, cancer survivorship, Colleen Cuthbert, MASCC 2025, Medical
care for cancersupportivesurvivorsevolvemascc